Gerd U. Auffarth's most recent trade in Outlook Therapeutics Inc was a trade of 56,636 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Oct. 1, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Outlook Therapeutics Inc | Gerd U. Auffarth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 56,636 | 56,636 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Gerd U. Auffarth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 29,493 | 29,493 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Gerd U. Auffarth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 12,082 | 12,082 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Gerd U. Auffarth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 94,441 | 94,441 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Gerd U. Auffarth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 41,065 | 41,065 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Gerd U. Auffarth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2022 | 42,239 | 42,239 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Gerd U. Auffarth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2022 | 21,878 | 21,878 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Gerd U. Auffarth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 25,245 | 25,245 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Gerd U. Auffarth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2021 | 20,873 | 20,873 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Gerd U. Auffarth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2020 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Gerd U. Auffarth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 19,874 | 19,874 | - | - | Stock Option (Right to Buy) |